- Home
- ITIC vs VSTM Comparison
ITIC vs VSTM Comparison
Compare ITIC & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITIC
- VSTM
- Stock Information
- Founded
- ITIC 1972
- VSTM 2010
- Country
- ITIC United States
- VSTM United States
- Employees
- ITIC N/A
- VSTM N/A
- Industry
- ITIC Specialty Insurers
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- ITIC Finance
- VSTM Health Care
- Exchange
- ITIC Nasdaq
- VSTM Nasdaq
- Market Cap
- ITIC 440.1M
- VSTM 425.9M
- IPO Year
- ITIC N/A
- VSTM 2012
- Fundamental
- Price
- ITIC $195.87
- VSTM $6.42
- Analyst Decision
- ITIC
- VSTM Strong Buy
- Analyst Count
- ITIC 0
- VSTM 8
- Target Price
- ITIC N/A
- VSTM $12.71
- AVG Volume (30 Days)
- ITIC 90.6K
- VSTM 2.6M
- Earning Date
- ITIC 08-05-2025
- VSTM 05-13-2025
- Dividend Yield
- ITIC 0.94%
- VSTM N/A
- EPS Growth
- ITIC 18.56
- VSTM N/A
- EPS
- ITIC 15.69
- VSTM N/A
- Revenue
- ITIC $261,197,999.00
- VSTM $10,000,000.00
- Revenue This Year
- ITIC N/A
- VSTM $106.87
- Revenue Next Year
- ITIC N/A
- VSTM $312.95
- P/E Ratio
- ITIC $12.37
- VSTM N/A
- Revenue Growth
- ITIC 15.27
- VSTM N/A
- 52 Week Low
- ITIC $168.74
- VSTM $2.10
- 52 Week High
- ITIC $290.40
- VSTM $9.10
- Technical
- Relative Strength Index (RSI)
- ITIC 29.02
- VSTM 44.06
- Support Level
- ITIC $190.20
- VSTM $5.73
- Resistance Level
- ITIC $235.99
- VSTM $6.33
- Average True Range (ATR)
- ITIC 8.84
- VSTM 0.75
- MACD
- ITIC -5.20
- VSTM -0.23
- Stochastic Oscillator
- ITIC 9.11
- VSTM 20.47
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.